In last trading session, Zura Bio Ltd (NASDAQ:ZURA) saw 0.53 million shares changing hands with its beta currently measuring 0.14. Company’s recent per share price level of $4.58 trading at $0.11 or 2.46% at ring of the bell on the day assigns it a market valuation of $292.09M. That closing price of ZURA’s stock is at a discount of -38.65% from its 52-week high price of $6.35 and is indicating a premium of 56.33% from its 52-week low price of $2.00. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.38 million shares which gives us an average trading volume of 433.49K if we extend that period to 3-months.
For Zura Bio Ltd (ZURA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.29. Splitting up the data highlights that, out of 11 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 8 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.15 in the current quarter.
Zura Bio Ltd (NASDAQ:ZURA) trade information
Upright in the green during last session for gaining 2.46%, in the last five days ZURA remained trading in the green while hitting it’s week-highest on Friday, 11/08/24 when the stock touched $4.58 price level, adding 2.55% to its value on the day. Zura Bio Ltd’s shares saw a change of -1.93% in year-to-date performance and have moved 4.57% in past 5-day. Zura Bio Ltd (NASDAQ:ZURA) showed a performance of 18.65% in past 30-days. Number of shares sold short was 1.88 million shares which calculate 2.88 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 54.2% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 15. It follows that stock’s current price would drop -9.17% in reaching the projected high whereas dropping to the targeted low would mean a loss of -9.17% for stock’s current value.
Zura Bio Ltd (ZURA) estimates and forecasts
Statistics highlight that Zura Bio Ltd is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -2.14% of value to its shares in past 6 months, showing an annual growth rate of 76.56% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Zura Bio Ltd (NASDAQ:ZURA)’s Major holders
Insiders are in possession of 32.63% of company’s total shares while institution are holding 53.67 percent of that, with stock having share float percentage of 79.67%. Investors also watch the number of corporate investors in a company very closely, which is 53.67% institutions for Zura Bio Ltd that are currently holding shares of the company.
